retatrutide available Unapproved weight loss drug causes extreme side effects Retatrutide Peptide Therapy | California

The STEP trials and real-world follow-up data show that weight regain begins immediately after stopping and accelerates over months

Zo is particularly interested in improving public understanding of obesity as a chronic condition and ensuring patients have access to accurate, accessible health information grounded in current scientific evidence

doi: 10.1172/JCI110335 55 ObenJMorganLFletcherJMarksV

For women of childbearing potential, these medications are not recommended during pregnancy or breastfeeding, and discontinuation is advised at least 2 months before planned pregnancy for semaglutide and 1 month for tirzepatide

Nature Reviews Endocrinology